Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now. |
Preclinical Therapeutics Development for NeuroAIDS (R21)
Release Date: August 21, 2006
Announcement Number: PA-06-528
Application Receipt Date:
September 1, 2006
January 2, 2007
May 1, 2007
September 1, 2007
January 2, 2008
May 1, 2008
September 1, 2008
January 2, 2009
Funding Contact: May Wong, Ph.D.
Program Area: Neural Environment
Brief Description:
The purpose of this Funding Opportunity Announcement (FOA) is to encourage the development and/or validation of new in vitro
and in vivo models of HIV or HAART-related neurotoxicity that show promise for use in the screening of novel CNS and PNS-targeted
therapeutic compounds. Ideally, such models would facilitate the screening of compounds or therapeutic approaches which protect
neuronal and glial cells of the CNS from damage in response to HIV and possibly other stresses, such as injury or associated
inflammatory insults.
Choose an option to view additional funding announcements |
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives |